Power Rangers' solid debut this weekend wasn't enough to dethrone Beauty and the Beast, as Disney's live-action film held strong in first place at the domestic box office for its second consecutive week.
As noted by Variety, Lionsgate's Mighty Morphin movie performed above its $30 million expectations, placing second with an estimated $40.5 million. The Dean Israelite-directed film, which cost $100 million to make, will serve as the start of a six-movie story that producer Haim Saban has planned.
Meanwhile, Beauty and the Beast enjoyed the fourth-largest second weekend ever, remaining box office champ with an estimated $88.3 million. Disney's live-action film, which had the sixth-biggest opening weekend in domestic box office history, trails the second-weekend hauls of Star Wars: The Force Awakens ($149.2 million), Jurassic World ($106.6 million) and Marvel's The Avengers ($103.1 million).
This March has proven to be the biggest in domestic box office history. Sales have reached $1 billion, which, until now, has never been achieved in the month of March.
Sony and Skydance Media's new sci-fi thriller Life didn't have a particularly strong performance, debuting in fourth place with an estimated $12.6 million. The film, which stars Ryan Reynolds, Rebecca Ferguson and Jake Gyllenhaal, boasts a production budget of $58 million.
CHiPS, the new crime comedy from Warner Bros. and director Dax Shepard, underwhelmed during its opening weekend, placing seventh with $7.6 million. The Erik Estrada and Larry Wilcox-led film cost $25 million to make.
Here are the top 10 weekend box office three-day estimates via comScore:
1. Beauty and the Beast $88.3 million
2. Power Rangers $40.5 million
3. Kong: Skull Island $14.4 million
4. Life $12.6 million
5. Logan $10.1 million
6. Get Out $8.7 million
7. CHiPS $7.6 million
8. The Shack $3.8 million
9. The LEGO Batman Movie $2 million
10. MET Opera: Idomeneo $1.3 million
Alex Osborn is a freelance writer for IGN. You can follow him on Twitter and subscribe to his YouTube channel.
Aucun commentaire:
Enregistrer un commentaire